DSIP (Delta Sleep-Inducing Peptide) — nonapeptide for sleep modulation
In short
Studied for how it may help your body achieve a deeper, more restful sleep. Research suggests it could improve how well you relax and recover overnight.
Overview
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) discovered in 1974 in rabbit brain. Originally isolated for its sleep-promoting properties, DSIP has since been found to have diverse neuromodulatory effects including stress reduction, pain modulation, and endocrine regulation, though its exact mechanisms and clinical efficacy remain subjects of ongoing research.
Modulates multiple neurotransmitter systems including GABA enhancement, NMDA receptor interaction, and endogenous opioid system modulation. Also regulates hypothalamic-pituitary-adrenal axis.
Molecular information
Research indications
Grouped by area. Each entry reflects a separate published hypothesis or clinical signal - not medical advice.
Unique sleep modulator - does not change circadian rhythm (as melatonin), but amplifies delta wave amplitude once sleep onset is established.
Понася се добре с минимални странични ефекти. Някои потребители съобщават за лека сънливост или замаяност в началото. Има случайни съобщения за главоболие при чувствителни индивиди. Проучванията не отчитат развитие на толерантност или зависимост. Избягвайте шофиране, докато не установите ефектите върху организма. Не се препоръчва по време на бременност или кърмене. Сигнали за спиране: Прекомерна дневна седация; Парадоксално безсъние или възбуда; Персистиращо главоболие; Всякакви алергични реакции; Промени в настроението или депресия; Необичайни сънища, причиняващи дистрес.
3 peer-reviewed sources
References
Links to peer-reviewed publications on PubMed, cited in the peptide's scientific profile.
Monnier - Discovery
Foundational | Various | Various | DSIP identification via cross-circulation
Eur Neurol · 1977
View the studyInformation about DSIP is based on published scientific research and is intended for research purposes only. Not medical advice.
Products are for in vitro laboratory research only. Not approved for human consumption.
Other peptides
5-Amino-1MQ
5-Amino-1MQ is a small-molecule selective inhibitor of NNMT (nicotinamide N-methyltransferase), identified by Anthony Sauve (Cornell) in 2018. NNMT is a "metabolic sink" for methyl donors and NAD+ — suppressing it in adipocytes raises energy expenditure without reducing calorie intake.
ReadAdipotide
Adipotide is a target peptide developed by Wadih Arap and Renata Pasqualini (MD Anderson) for selective elimination of white adipose tissue. It binds prohibitin on adipocyte vasculature and induces apoptosis of the blood vessels supplying fat tissue — leading to nonsurgical fat reduction.
ReadAOD-9604
AOD-9604 is a modified C-terminal 16-amino-acid fragment of human growth hormone (177-191), supplemented with a tyrosine residue. Retains the lipolytic effect of the full molecule but without diabetogenic or GH-stimulating activity. Developed by Metabolic Pharmaceuticals (Australia) in the 1990s.
ReadARA-290
ARA-290 (Cibinetide) is an 11-amino-acid fragment of erythropoietin (EPO) developed by Anthony Cerami as a cytoprotective molecule without erythropoietic activity. It retains the tissue-protective effects of EPO without raising hematocrit — explaining its potential in diabetic neuropathy and cardiac applications.
ReadArgireline
Argireline is a synthetic acetylated hexapeptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) derived from SNAP-25 — the SNARE complex subunit mediating acetylcholine release at neuromuscular junctions. Topical application reduces muscle activity in expression areas — which is why Argireline is marketed as a "topical Botox alternative".
ReadBPC-157
BPC-157 is a 15-amino-acid fragment isolated from a protective protein in human gastric juice — hence the name Body Protection Compound. Over thirty years of research by Predrag Sikiric's group at the University of Zagreb (100+ peer-reviewed papers) establish its angiogenic action through the VEGFR2 receptor and its stimulation of fibroblasts. If you work with in vitro models of tendon, muscle or gut tissue, BPC-157 is among the most extensively documented regenerative peptides.
ReadNo comments yet. Be the first.
Comments are reviewed before publishing.
